Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

SciClone's Zadaxin boosts immune recognition of tumor cells

March 8, 2000

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Antitumor immunity induced by elemene involves enhancement of HSP70 expression

March 2, 2000

GVAX lung cancer vaccine advances to multicenter phase I/II trials

March 1, 2000

Monoclonal antibody targeting Lewis X combined with chemotherapy in breast cancer

Feb. 29, 2000

Second orphan drug designation granted for Maxamine

Feb. 25, 2000

Phase III data presented for Corixa's melanoma vaccine

Feb. 22, 2000

Results of phase II Multikine cancer study promising

Feb. 22, 2000

Aventis and MediGene to codevelop melanoma vaccine

Feb. 21, 2000

Campath BLA accepted for filing

Feb. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...